Delox

company

About

Delox is designing and developing a new generation of bio-decontamination devices.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
€200K
Industries
Biotechnology,Health Care,Hospital
Founded date
Jan 1, 2018
Number Of Employee
1 - 10
Operating Status
Active

Delox is a spin-off of the Faculty of Sciences of the University of Lisbon (FCUL), whose goals consist in the design, development, and production of a vast portfolio of automatic biodecontamination robots. Target applications include the sterilization of medical devices in hospitals, health centers and field hospitals (for humanitarian missions, catastrophe situations, and war zones); room biodecontamination in hospitals, pharma, food industry and space; and laboratory equipment biodecontamination.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€1.25M
Delox has raised a total of €1.25M in funding over 2 rounds. Their latest funding was raised on May 18, 2022 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 18, 2022 Seed €750K 1 Detail
Jul 1, 2018 Grant €200K 1 Detail
Jul 1, 2018 Seed €300K 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Delox is funded by 2 investors. Bionova Capital and H2020-SME-Instrument program are the most recent investors.
Investor Name Lead Investor Funding Round
Bionova Capital Seed
H2020-SME-Instrument program Grant